Spravato Treatment

Spravato® Treatment for Treatment-Resistant Depression

Advanced Care When Traditional Treatments Haven't Worked

If you’ve tried multiple antidepressants without significant improvement, Spravato® may provide a new path toward recovery. At MindRx Psychiatry, we offer Spravato® treatment in a safe, comfortable, and medically supervised setting.

What Is Spravato®?

Spravato® (esketamine) is an FDA-approved prescription nasal spray used alongside an oral antidepressant to treat adults with treatment-resistant depression.

Unlike traditional antidepressants, Spravato® works differently within the brain and may provide faster symptom improvement for eligible patients.

Who May Benefit From Spravato®?

Spravato® may be recommended for adults who:

  • Have treatment-resistant depression
  • Have tried multiple antidepressants without success
  • Continue experiencing severe depressive symptoms
  • Require a different treatment approach
  • Meet eligibility requirements after psychiatric evaluation

Who May Benefit From Spravato®?

Spravato® may be recommended for adults who:

What To Expect During Treatment

Each Spravato® session includes:

  • Initial Evaluation – Our provider determines whether Spravato® is an appropriate treatment option.
  • Supervised Administration – The medication is administered in our office under medical supervision.
  • Observation Period – Patients remain in the clinic for monitoring after each treatment session to ensure safety.
  • Ongoing Care – Treatment progress is monitored regularly, with adjustments made when appropriate.

Benefits of Spravato®

  • FDA-approved treatment
  • Alternative option for treatment-resistant depression
  • Professionally supervised care
  • Personalized treatment planning
  • Comprehensive follow-up support

Take the Next Step

If depression continues despite previous treatment, Spravato® may provide another option worth exploring.